NEWS
New Publication Announcement!
Following on from LVPEI's successful proof of concept studies highlighting the successful use of Atelerix's technology to distribute a limbal-stromal cell therapy throughout India (Damala et al., 2019), we are delighted to announce the...
New Publication Announcement!
Following on from LVPEI's successful proof of concept studies highlighting the successful use of Atelerix's technology to distribute a limbal-stromal cell therapy throughout India (Damala et al., 2019), we are delighted to announce the...
CytoStor™ successfully preserves primary human ...
The liver microenvironment is proving to be a major obstacle to the success of immunotherapy in solid organ tumours. The liver is characterised by tolerogenic properties that lead to the...
CytoStor™ successfully preserves primary human ...
The liver microenvironment is proving to be a major obstacle to the success of immunotherapy in solid organ tumours. The liver is characterised by tolerogenic properties that lead to the...
Atelerix presents promising data for the applic...
Peripheral blood mononuclear cells (PBMCs), derived from whole blood or leukapheresis, encompass several major immune cell populations including lymphocytes, monocytes, NK cells and dendritic cells. Apheresis material is a PBMC-enriched...
Atelerix presents promising data for the applic...
Peripheral blood mononuclear cells (PBMCs), derived from whole blood or leukapheresis, encompass several major immune cell populations including lymphocytes, monocytes, NK cells and dendritic cells. Apheresis material is a PBMC-enriched...
New Publication Announcement!
Branco et al. have recently published an excellent paper showing the benefits of Atelerix technology in the preservation of Adipose-Derived Mesenchymal Stromal Cells. Demonstrating the maintenance of MSC viability and...
New Publication Announcement!
Branco et al. have recently published an excellent paper showing the benefits of Atelerix technology in the preservation of Adipose-Derived Mesenchymal Stromal Cells. Demonstrating the maintenance of MSC viability and...
CytoStor™ & the transport of precious cells
How preservation of urine can impact kidney disease research Background: Each day, 20 people in the UK alone, develop chronic kidney disease, while an estimated 3 million people in the...
CytoStor™ & the transport of precious cells
How preservation of urine can impact kidney disease research Background: Each day, 20 people in the UK alone, develop chronic kidney disease, while an estimated 3 million people in the...
TissueReady™ & Organoid Modelling
Pancreatic cancer is one of the most aggressive and lethal solid tumours. Pancreatic ductal adenocarcinoma (PDAC) describes malignancies of the exocrine pancreatic tissue, that account for 90% of all pancreatic...
TissueReady™ & Organoid Modelling
Pancreatic cancer is one of the most aggressive and lethal solid tumours. Pancreatic ductal adenocarcinoma (PDAC) describes malignancies of the exocrine pancreatic tissue, that account for 90% of all pancreatic...
